Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Accounts Payables (2016 - 2026)

Healthcare Services has reported Accounts Payables over the past 18 years, most recently at $83.1 million for Q1 2026.

  • Quarterly Accounts Payables rose 5.52% to $83.1 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $83.1 million through Mar 2026, up 5.52% year-over-year, with the annual reading at $77.4 million for FY2025, 4.64% down from the prior year.
  • Accounts Payables was $83.1 million for Q1 2026 at Healthcare Services, up from $77.4 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $83.2 million in Q4 2023 and troughed at $64.0 million in Q1 2022.
  • The 5-year median for Accounts Payables is $72.9 million (2024), against an average of $73.6 million.
  • Biggest five-year swings in Accounts Payables: soared 34.1% in 2022 and later dropped 4.64% in 2025.
  • Tracing HCSG's Accounts Payables over 5 years: stood at $68.3 million in 2022, then rose by 21.86% to $83.2 million in 2023, then decreased by 2.5% to $81.1 million in 2024, then dropped by 4.64% to $77.4 million in 2025, then rose by 7.42% to $83.1 million in 2026.
  • According to Business Quant data, Accounts Payables over the past three periods came in at $83.1 million, $77.4 million, and $81.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.